(MedPage Today) — The use of neoadjuvant chemotherapy failed to improve disease-free survival (DFS) over upfront surgery in patients with locally advanced colon cancer, a phase III randomized trial showed.
Among 248 patients, the DFS rate at…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
